arrow
P

Paul Timpson

The Kinghorn Cancer Centre
H指数:70
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Patient-derived models of prostate cancer: Capturing tumour complexity from initiation to metastasis

患者来源的前列腺癌模型:从起始到转移捕捉肿瘤复杂性

2026-08-010
OAAI
HSP47 is a potential dual cell target and prognostic factor in pancreatic cancer

HSP47是胰腺癌中一个潜在的双细胞靶点和预后因素

2026-06-210
OA
Endocrine therapy reprogramming of breast cancer facilitates metastatic escape via upregulation of P-Rex1/Rac1 signalling

内分泌疗法对乳腺癌的重编程通过上调P-Rex1/Rac1信号通路促进转移性逃逸

2026-05-110
OAAI
Impact of symptom and functional burden on survival in pancreatic ductal adenocarcinoma (PDAC)

症状和功能负担对胰腺导管腺癌(PDAC)生存期的影响

2024-09-010
PRE
Temporally resolved proteomics identifies nidogen-2 as a cotarget in pancreatic cancer that modulates fibrosis and therapy response

暂时分辨的蛋白质组学将nidogen-2鉴定为胰腺癌的共靶标,其调节纤维化和治疗反应

2024-07-052
OAAI
Tumor Biomechanics Alters Metastatic Dissemination of Triple Negative Breast Cancer via Rewiring Fatty Acid Metabolism

肿瘤生物力学通过重新连接脂肪酸代谢改变三阴性乳腺癌的转移扩散

2024-04-112
OA
Therapeutic blockade of ER stress and inflammation prevents NASH and progression to HCC

ER应激和炎症的治疗性阻断可防止NASH和进展为HCC

2023-09-1511
OAAI
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer

一种一流的泛赖氨酰氧化酶抑制剂可削弱胰腺癌的基质重塑并增强吉西他滨反应和生存率

2023-08-2823
OAAI
Monitoring AKT activity and targeting in live tissue and disease contexts using a real-time Akt-FRET biosensor mouse
2023-04-281
OAAI
Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastoma
2023-03-038
OAAI